Publicações

Patient-Reported Outcomes from Destiny-Breast04: Trastuzumab Deruxtecan Versus Physician's Choice of Chemotherapy in Patients with Her2-Low Mbc

AuthID
P-018-SYT

Author(s)

Ueno, NT

Cottone, F

Dunton, K

Jacot, W

Yamashita, T

Sohn, J

Tokunaga, E

Prat, A

Tsurutani, J

Park, YH

Rugo, HS

Xu, BH

Cardoso, F

Mitri, Z

Mahtani, R

Aguilar, CO

Xiao, F

Harbeck, N

Cameron, DA

Modi, S

Tipo de Documento

Article

Year published

2025

Publicado

in ONCOLOGIST, ISSN: 1083-7159

Volume: 30, Número: 5

Indexing

Wos^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1093/oncolo/oyaf048

Pubmed: 40349139

Wos: WOS:001484953200006

Source Identifiers

ISSN: 1083-7159

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Patient-Reported Outcomes from Destiny-Breast04: Trastuzumab Deruxtecan Versus Physician's Choice of Chemotherapy in Patients with Her2-Low Mbc

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Patient-Reported Outcomes from Destiny-Breast04: Trastuzumab Deruxtecan Versus Physician's Choice of Chemotherapy in Patients with Her2-Low Mbc

Links Úteis

Ajuda